IL6 and graft versus host disease: Notably, P2ry2−/− recipient mice, but not P2ry2−/− donor cells, displayed reduced clinical GVHD and increased survival, which corresponded to reduced histological GVHD, serum IL-6 concentrations and other inflammatory molecules compared to wt recipient mice [125].